Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)
      Description

      The purpose of this study is to demonstrate the non-inferiority of pafuramidine maleate (DB289)versus trimethoprim-sulfamethoxazole (TMP-SMX)for the treatment of mild to moderately severe Pneumocystis pneumonia (PCP).

      Conditions
      Pneumonia, Interstitial Plasma CellPneumocystis Carinii PneumoniaPneumonia, Pneumocystis CariniiHIV Infections
      Talk to us